Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

The aim of the Malaria & Critical Illness Department at MORU is to improve health through research that addresses threats arising from malaria for billions of people who live in malaria endemic zones around the globe.

Image1.jpeg © MORU 2019. Gerhard Jørén
Arjen Dondorp, Head of Malaria (back right) with Kesinee Chotivanich (front, 2nd right) and her Malaria Lab team.

Malaria Overview

Billions of people live in malaria endemic countries; we aim to improve health through research that addresses this threat.

Significant achievements

The Malaria & Critical Illness team published 96 papers in 2018, and 222 papers from 2015-2017, of which many in leading journals. Since its conception in 1979, the Malaria team has published over 1,000 papers.

Future vision

Following the large multi-centre multi-country TRAC II study on triple ACTs (TACTs) to treat multi-drug resistant falciparum malaria, DeTACT, a large project funded by DFID, will expand the evaluation of TACTs to African countries and aims to have 2 different TACTs ready for deployment by the end of the project.

Studies & study sites

The Malaria & Critical Illness Department has a vibrant and productive network of collaborative study sites throughout South-East Asia, South Asia and Africa, with around 15 studies currently operating in a total of an equal number of countries.